OMCL
Omnicell, Inc.
Price Chart
Latest Quote
$38.68
-0.37 (-0.95%)
Current Price
| Previous Close | $39.05 |
| Open | $38.69 |
| Day High | $39.43 |
| Day Low | $38.57 |
| Volume | 756,536 |
Stock Information
| Shares Outstanding | 45.48M |
| Total Debt | $202.18M |
| Cash Equivalents | $239.22M |
| Revenue | $1.23B |
| Net Income | $20.43M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $1.76B |
| P/E Ratio | 87.91 |
| EPS (TTM) | $0.44 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.72B |
| Sales | $1.23B |
| Income | $20.43M |
| Book/sh | $27.63 |
| Cash/sh | $5.26 |
| Employees | 4K |
Financial Ratios
| Quick Ratio | 1.04 |
| Current Ratio | 1.50 |
| Debt/Eq | 16.09 |
Returns & Margins
| ROA | 1.21% |
| ROE | 1.63% |
| Gross Margin | 43.87% |
| Operating Margin | 5.44% |
| Profit Margin | 1.67% |
Ownership
| Insider Ownership | 2.22% |
| Institutional Ownership | 106.03% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 17.62 |
| PEG | 15.40 |
| P/S | 1.44 |
| P/B | 1.40 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $61.29 |
Technical Indicators
| SMA20 | $41.33 |
| SMA50 | $41.03 |
| SMA200 | $38.78 |
| RSI | 33.21 |
| ATR | 1.8179 |
| Shares Float | 41.94M |
| Short Float | 7.94% |
| Short Ratio | 5.17 |
| Volatility | 0.96 |
| Rel Volume | 1.24 |
Performance History
| Week | +2.25% |
| Month | -13.51% |
| Quarter | +16.89% |
| 6 Months | -15.53% |
| YTD | -14.31% |
| Year | +36.82% |
| 3 Years | -46.44% |
| 5 Years | -72.95% |
| 10 Years | +15.43% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $38.68 | 804,100 |
| 2026-06-18 | $39.05 | 1,347,200 |
| 2026-06-17 | $38.50 | 618,600 |
| 2026-06-16 | $39.90 | 627,300 |
| 2026-06-15 | $39.99 | 943,200 |
| 2026-06-12 | $37.83 | 612,400 |
| 2026-06-11 | $37.82 | 1,376,400 |
| 2026-06-10 | $38.18 | 792,000 |
| 2026-06-09 | $40.69 | 692,100 |
| 2026-06-08 | $41.95 | 583,800 |
| 2026-06-05 | $43.00 | 337,300 |
| 2026-06-04 | $43.60 | 419,600 |
| 2026-06-03 | $41.89 | 539,900 |
| 2026-06-02 | $41.91 | 529,700 |
| 2026-06-01 | $43.16 | 640,100 |
| 2026-05-29 | $44.14 | 675,500 |
| 2026-05-28 | $44.72 | 306,700 |
| 2026-05-27 | $43.12 | 401,800 |
| 2026-05-26 | $44.10 | 399,500 |
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
đ° Latest News
3 of Wall Streetâs Favorite Stocks with Questionable Fundamentals
StockStory âĸ 2026-06-19T14:04:58Z
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks âĸ 2026-06-10T15:40:03Z
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
StockStory âĸ 2026-06-09T09:02:14Z
3 Russell 2000 Stocks That Fall Short
StockStory âĸ 2026-06-08T16:37:50Z
Omnicell Shareholders Back Governance Amendment And Long Term Growth Focus
Simply Wall St. âĸ 2026-06-07T19:07:41Z
Wall Street Analysts Predict a 40.57% Upside in Omnicell (OMCL): Here's What You Should Know
Zacks âĸ 2026-06-05T13:55:04Z
Omnicell (OMCL) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks âĸ 2026-06-05T13:50:03Z
Is Omnicell Stock a Smart Addition to Your Portfolio Now?
Zacks âĸ 2026-06-04T13:59:00Z
Omnicell (OMCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Zacks âĸ 2026-06-04T13:55:02Z
3 Healthcare Stocks We Think Twice About
StockStory âĸ 2026-05-29T18:24:38Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $681,403,000 | $641,235,000 | $650,272,000 | $706,960,000 |
| Cost Of Revenue | $681,403,000 | $641,235,000 | $650,272,000 | $706,960,000 |
| Total Revenue | $1,184,845,000 | $1,112,238,000 | $1,147,112,000 | $1,295,947,000 |
| Operating Revenue | $1,184,845,000 | $1,112,238,000 | $1,147,112,000 | $1,295,947,000 |
| Expenses | ||||
| Total Expenses | $1,179,685,000 | $1,111,901,000 | $1,181,980,000 | $1,298,270,000 |
| Net Non Operating Interest Income Expense | $6,165,000 | $25,256,000 | $14,760,000 | $-130,000 |
| Total Other Finance Cost | $-6,165,000 | $-25,256,000 | $-14,760,000 | $130,000 |
| Operating Expense | $498,282,000 | $470,666,000 | $531,708,000 | $591,310,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Net Interest Income | $6,165,000 | $25,256,000 | $14,760,000 | $-130,000 |
| Normalized Income | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Net Income From Continuing And Discontinued Operation | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Total Operating Income As Reported | $5,160,000 | $337,000 | $-34,868,000 | $-2,323,000 |
| Net Income Common Stockholders | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Net Income | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Net Income Including Noncontrolling Interests | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Net Income Continuous Operations | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Pretax Income | $11,325,000 | $25,593,000 | $-20,108,000 | $-2,453,000 |
| Operating Income | $5,160,000 | $337,000 | $-34,868,000 | $-2,323,000 |
| Gross Profit | $503,442,000 | $471,003,000 | $496,840,000 | $588,987,000 |
| Per Share | ||||
| Diluted EPS | $0.04 | $0.27 | $-0.45 | $0.12 |
| Basic EPS | $0.04 | $0.27 | $-0.45 | $0.13 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $91,794,000 | $90,092,000 | $60,690,000 | $96,846,000 |
| Reconciled Depreciation | $86,634,000 | $89,755,000 | $95,558,000 | $99,169,000 |
| EBITDA (Bullshit earnings) | $91,794,000 | $90,092,000 | $60,690,000 | $96,846,000 |
| EBIT | $5,160,000 | $337,000 | $-34,868,000 | $-2,323,000 |
| Diluted Average Shares | $46,362,000 | $46,255,000 | $45,212,000 | $45,891,000 |
| Basic Average Shares | $45,965,000 | $46,047,000 | $45,212,000 | $44,398,000 |
| Diluted NI Availto Com Stockholders | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Tax Provision | $9,273,000 | $13,062,000 | $263,000 | $-8,101,000 |
| Research And Development | $88,672,000 | $90,412,000 | $97,115,000 | $104,969,000 |
| Selling General And Administration | $409,610,000 | $380,254,000 | $434,593,000 | $486,341,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $269,566,000 | $261,884,000 | $175,312,000 | $72,197,000 |
| Total Assets | $1,974,720,000 | $2,120,960,000 | $2,226,878,000 | $2,210,758,000 |
| Total Non Current Assets | $1,294,651,000 | $1,305,467,000 | $1,299,307,000 | $1,328,946,000 |
| Other Non Current Assets | $10,322,000 | $10,057,000 | $8,239,000 | $7,455,000 |
| Non Current Prepaid Assets | $52,840,000 | $54,656,000 | $52,414,000 | $59,483,000 |
| Non Current Deferred Assets | $60,501,000 | $60,409,000 | $36,619,000 | $24,387,000 |
| Non Current Deferred Taxes Assets | $58,337,000 | $57,469,000 | $32,901,000 | $22,329,000 |
| Non Current Accounts Receivable | $3,521,000 | $7,873,000 | $11,850,000 | $14,744,000 |
| Goodwill And Other Intangible Assets | $962,248,000 | $981,429,000 | $1,013,642,000 | $1,057,940,000 |
| Other Intangible Assets | $224,302,000 | $246,702,000 | $277,832,000 | $323,666,000 |
| Current Assets | $680,069,000 | $815,493,000 | $927,571,000 | $881,812,000 |
| Other Current Assets | $3,670,000 | $4,934,000 | $7,714,000 | $7,471,000 |
| Current Deferred Assets | $10,819,000 | $8,704,000 | - | - |
| Restricted Cash | $101,104,000 | $47,846,000 | $43,649,000 | $56,703,000 |
| Prepaid Assets | $35,545,000 | $27,276,000 | $34,245,000 | $28,772,000 |
| Inventory | $100,905,000 | $88,659,000 | $110,099,000 | $147,549,000 |
| Receivables | $216,858,000 | $256,398,000 | $252,025,000 | $299,469,000 |
| Accounts Receivable | $216,858,000 | $256,398,000 | $252,025,000 | $299,469,000 |
| Allowance For Doubtful Accounts Receivable | $-8,868,000 | $-6,645,000 | $-5,564,000 | $-5,153,000 |
| Gross Accounts Receivable | $225,726,000 | $263,043,000 | $257,589,000 | $304,622,000 |
| Cash Cash Equivalents And Short Term Investments | $211,168,000 | $381,676,000 | $479,839,000 | $341,848,000 |
| Cash And Cash Equivalents | $196,520,000 | $369,201,000 | $467,972,000 | $330,362,000 |
| Cash Equivalents | $148,600,000 | $328,000,000 | $451,000,000 | $301,000,000 |
| Cash Financial | $47,920,000 | $41,201,000 | $16,972,000 | $29,362,000 |
| Debt | ||||
| Total Debt | $204,345,000 | $382,546,000 | $614,090,000 | $616,737,000 |
| Long Term Debt And Capital Lease Obligation | $192,390,000 | $197,520,000 | $603,572,000 | $605,976,000 |
| Long Term Debt | $167,596,000 | $166,397,000 | $569,662,000 | $566,571,000 |
| Current Debt And Capital Lease Obligation | $11,955,000 | $185,026,000 | $10,518,000 | $10,761,000 |
| Current Debt | - | $174,324,000 | - | - |
| Other Current Borrowings | - | $174,324,000 | - | - |
| Net Debt | - | - | $101,690,000 | $236,209,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $742,906,000 | $877,647,000 | $1,037,924,000 | $1,080,621,000 |
| Total Non Current Liabilities Net Minority Interest | $266,297,000 | $281,969,000 | $670,132,000 | $652,175,000 |
| Other Non Current Liabilities | $9,970,000 | $7,218,000 | $6,318,000 | $6,719,000 |
| Non Current Deferred Liabilities | $63,937,000 | $77,231,000 | $60,242,000 | $39,480,000 |
| Non Current Deferred Taxes Liabilities | $683,000 | $1,108,000 | $1,620,000 | $2,095,000 |
| Current Liabilities | $476,609,000 | $595,678,000 | $367,792,000 | $428,446,000 |
| Current Deferred Liabilities | $283,479,000 | $201,976,000 | $175,934,000 | $187,206,000 |
| Payables And Accrued Expenses | $124,003,000 | $148,369,000 | $129,586,000 | $157,024,000 |
| Payables | $48,007,000 | $63,225,000 | $47,219,000 | $73,031,000 |
| Total Tax Payable | $4,017,000 | $11,443,000 | $2,191,000 | $9,642,000 |
| Accounts Payable | $43,990,000 | $51,782,000 | $45,028,000 | $63,389,000 |
| Equity | ||||
| Common Stock Equity | $1,231,814,000 | $1,243,313,000 | $1,188,954,000 | $1,130,137,000 |
| Total Equity Gross Minority Interest | $1,231,814,000 | $1,243,313,000 | $1,188,954,000 | $1,130,137,000 |
| Stockholders Equity | $1,231,814,000 | $1,243,313,000 | $1,188,954,000 | $1,130,137,000 |
| Gains Losses Not Affecting Retained Earnings | $-8,854,000 | $-17,195,000 | $-13,432,000 | $-17,087,000 |
| Other Equity Adjustments | $-8,854,000 | $-17,195,000 | $-13,432,000 | $-17,087,000 |
| Retained Earnings | $384,940,000 | $382,888,000 | $370,357,000 | $390,728,000 |
| Other | ||||
| Treasury Shares Number | $12,806,000 | $10,283,000 | $10,283,000 | $10,283,000 |
| Ordinary Shares Number | $45,027,000 | $46,382,000 | $45,539,000 | $44,747,000 |
| Share Issued | $57,833,000 | $56,665,000 | $55,822,000 | $55,030,000 |
| Tangible Book Value | $269,566,000 | $261,884,000 | $175,312,000 | $72,197,000 |
| Working Capital | $203,460,000 | $219,815,000 | $559,779,000 | $453,366,000 |
| Capital Lease Obligations | $36,749,000 | $41,825,000 | $44,428,000 | $50,166,000 |
| Total Capitalization | $1,399,410,000 | $1,409,710,000 | $1,758,616,000 | $1,696,708,000 |
| Treasury Stock | $368,307,000 | $290,319,000 | $290,319,000 | $290,319,000 |
| Additional Paid In Capital | $1,223,977,000 | $1,167,882,000 | $1,122,292,000 | $1,046,760,000 |
| Capital Stock | $58,000 | $57,000 | $56,000 | $55,000 |
| Common Stock | $58,000 | $57,000 | $56,000 | $55,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $63,254,000 | $76,123,000 | $58,622,000 | $37,385,000 |
| Long Term Capital Lease Obligation | $24,794,000 | $31,123,000 | $33,910,000 | $39,405,000 |
| Current Deferred Revenue | $283,479,000 | $201,976,000 | $175,934,000 | $187,206,000 |
| Current Capital Lease Obligation | $11,955,000 | $10,702,000 | $10,518,000 | $10,761,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $57,172,000 | $60,307,000 | $51,754,000 | $73,455,000 |
| Current Accrued Expenses | $75,996,000 | $85,144,000 | $82,367,000 | $83,993,000 |
| Investments And Advances | $60,742,000 | $52,744,000 | $42,954,000 | $32,924,000 |
| Other Investments | $60,742,000 | $52,744,000 | $42,954,000 | $32,924,000 |
| Goodwill | $737,946,000 | $734,727,000 | $735,810,000 | $734,274,000 |
| Net PPE | $144,477,000 | $138,299,000 | $133,589,000 | $132,013,000 |
| Accumulated Depreciation | $-196,549,000 | $-168,393,000 | $-139,432,000 | $-126,644,000 |
| Gross PPE | $341,026,000 | $306,692,000 | $273,021,000 | $258,657,000 |
| Leases | $18,606,000 | $17,722,000 | $17,919,000 | $19,510,000 |
| Construction In Progress | $23,426,000 | $12,539,000 | $11,614,000 | $28,223,000 |
| Other Properties | $128,437,000 | $125,335,000 | $120,984,000 | $129,443,000 |
| Machinery Furniture Equipment | $170,557,000 | $151,096,000 | $122,504,000 | $81,481,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $73,339,000 | $53,643,000 | $57,333,000 | $62,415,000 |
| Work In Process | $1,321,000 | $1,515,000 | $1,327,000 | $9,280,000 |
| Raw Materials | $26,245,000 | $33,501,000 | $51,439,000 | $75,854,000 |
| Other Short Term Investments | $14,648,000 | $12,475,000 | $11,867,000 | $11,486,000 |
| Foreign Currency Translation Adjustments | - | - | - | $-17,087,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $69,367,000 | $134,929,000 | $126,078,000 | $17,041,000 |
| Operating Activities | ||||
| Operating Cash Flow | $127,300,000 | $187,722,000 | $181,094,000 | $77,781,000 |
| Cash Flow From Continuing Operating Activities | $127,300,000 | $187,722,000 | $181,094,000 | $77,781,000 |
| Operating Gains Losses | $488,000 | $-6,539,000 | $2,572,000 | $678,000 |
| Investing Activities | ||||
| Capital Expenditure | $-57,933,000 | $-52,793,000 | $-55,016,000 | $-60,740,000 |
| Investing Cash Flow | $-60,363,000 | $-52,793,000 | $-55,016,000 | $-58,669,000 |
| Cash Flow From Continuing Investing Activities | $-60,363,000 | $-52,793,000 | $-55,016,000 | $-58,669,000 |
| Net Other Investing Changes | $-2,430,000 | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-77,600,000 | $0 | $0 | $-52,210,000 |
| Financing Cash Flow | $-218,317,000 | $-235,578,000 | $23,420,000 | $-20,953,000 |
| Cash Flow From Continuing Financing Activities | $-218,317,000 | $-235,578,000 | $23,420,000 | $-20,953,000 |
| Net Other Financing Charges | $17,415,000 | $-48,702,000 | $204,000 | $-8,925,000 |
| Net Common Stock Issuance | $-77,600,000 | $0 | $0 | $-52,210,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-175,000,000 | $-391,727,000 | $0 | $0 |
| Issuance Of Debt | $0 | $166,272,000 | $0 | $0 |
| Interest Paid Supplemental Data | $2,201,000 | $1,624,000 | $1,438,000 | $1,438,000 |
| End Cash Position | $251,032,000 | $398,614,000 | $500,979,000 | $352,835,000 |
| Beginning Cash Position | $398,614,000 | $500,979,000 | $352,835,000 | $355,620,000 |
| Effect Of Exchange Rate Changes | $3,798,000 | $-1,716,000 | $-1,354,000 | $-944,000 |
| Changes In Cash | $-151,380,000 | $-100,649,000 | $149,498,000 | $-1,841,000 |
| Proceeds From Stock Option Exercised | $16,868,000 | $38,579,000 | $23,216,000 | $40,182,000 |
| Common Stock Payments | $-77,600,000 | $0 | $0 | $-52,210,000 |
| Net Issuance Payments Of Debt | $-175,000,000 | $-225,455,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-175,000,000 | $-225,455,000 | $0 | $0 |
| Long Term Debt Payments | $-175,000,000 | $-391,727,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $166,272,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-17,518,000 | $-16,330,000 | $-13,542,000 | $-13,204,000 |
| Purchase Of Intangibles | $-17,518,000 | $-16,330,000 | $-13,542,000 | $-13,204,000 |
| Net PPE Purchase And Sale | $-40,415,000 | $-36,463,000 | $-41,474,000 | $-47,536,000 |
| Purchase Of PPE | $-40,415,000 | $-36,463,000 | $-41,474,000 | $-47,536,000 |
| Change In Working Capital | $-8,333,000 | $58,333,000 | $43,673,000 | $-73,466,000 |
| Change In Other Working Capital | $16,379,000 | $28,952,000 | $24,058,000 | $24,469,000 |
| Change In Other Current Liabilities | $-9,853,000 | $-9,837,000 | $-11,319,000 | $-14,480,000 |
| Change In Other Current Assets | $-6,858,000 | $1,100,000 | $-15,121,000 | $-3,967,000 |
| Change In Payables And Accrued Expense | $-32,249,000 | $29,705,000 | $-49,329,000 | $11,343,000 |
| Change In Accrued Expense | $-22,966,000 | $22,495,000 | $-31,804,000 | $19,097,000 |
| Change In Payable | $-9,283,000 | $7,210,000 | $-17,525,000 | $-7,754,000 |
| Change In Account Payable | $-9,283,000 | $7,210,000 | $-17,525,000 | $-7,754,000 |
| Change In Prepaid Assets | $-5,951,000 | $-2,218,000 | $8,218,000 | $-359,000 |
| Change In Inventory | $-11,225,000 | $15,633,000 | $38,016,000 | $-30,115,000 |
| Change In Receivables | $41,424,000 | $-5,002,000 | $49,150,000 | $-60,357,000 |
| Other Non Cash Items | $2,651,000 | $3,788,000 | $4,397,000 | $4,164,000 |
| Stock Based Compensation | $44,502,000 | $39,316,000 | $55,300,000 | $68,247,000 |
| Asset Impairment Charge | $599,000 | $5,393,000 | $11,012,000 | $10,657,000 |
| Deferred Tax | $-1,293,000 | $-14,855,000 | $-11,047,000 | $-37,316,000 |
| Deferred Income Tax | $-1,293,000 | $-14,855,000 | $-11,047,000 | $-37,316,000 |
| Depreciation Amortization Depletion | $86,634,000 | $89,755,000 | $95,558,000 | $99,169,000 |
| Depreciation And Amortization | $86,634,000 | $89,755,000 | $95,558,000 | $99,169,000 |
| Depreciation | $86,634,000 | $89,755,000 | $95,558,000 | $99,169,000 |
| Gain Loss On Sale Of PPE | $488,000 | $978,000 | $2,572,000 | $678,000 |
| Net Income From Continuing Operations | $2,052,000 | $12,531,000 | $-20,371,000 | $5,648,000 |
| Income Tax Paid Supplemental Data | - | $11,279,000 | $20,209,000 | $19,005,000 |
| Net Business Purchase And Sale | - | $0 | $0 | $2,071,000 |
| Sale Of Business | - | $0 | $0 | $5,463,000 |
| Purchase Of Business | - | $0 | $0 | $-3,392,000 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-18